Delivery Order SPE2DB24D3014-SPE2DB25FKRYC
Award Date
11/5/24
Potential Completion Date
11/6/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,665.54, is a Delivery Order for the supply of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of June 13, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $7,511.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,653.37, is for the delivery of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product. The contract is a delivery order with a firm fixed price, and the period of performance extends through May 12, 2025. The contract is not set-aside and is open to competition. AmerisourceBergen Drug Corp holds...
This federal contract award, valued at $11,286.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024 and is a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,585.18 firm fixed-price delivery order contract is for the supply of XELJANZ XR 11 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award, valued at $11,923.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of XELJANZ XR 11 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $6,882.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and covers the supply of XELJANZ XR 11 MG TABLET for the government. The award has an ultimate completion date of December 6, 2024. This contract is not set aside for any specific business category. AmerisourceBergen holds a significant...
This federal contract award, valued at $14,772.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of the prescription medication XELJANZ 5 MG TABLET, with an ultimate completion date of April 21, 2025. The contract is a firm fixed-price, non-set-aside vehicle, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $91,750.91. The contract, awarded by the Defense Logistics Agency (DLA), is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of April 21, 2023 and is a firm fixed price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is a delivery order worth $49,875.87 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. It is a firm fixed price contract with a completion date of February 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...